Research | OneLook Acronym Finder |
Serial Number | 98013156 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
Attorney Name | Christina M. Licursi |
Attorney Docket Number | A13892000300 |
2023-05-25 | Application Filed |
2023-06-26 | Location: NEW APPLICATION PROCESSING |
2023-06-26 | Status: Live/Pending |
2023-06-27 | Transaction Date |
Owner: | ARTBIO, Inc. |
Address | c/o F-Prime Capital One Main Street, 13th Floor Cambridge DE 02142 |
Legal Entity Type | Corporation |
Legal Entity State | DE |
Application | 2023-05-25 | |
Drawing | 2023-05-25 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0051 | Drug delivery agents and devices used for the manufacture, production and delivery of targeted radiation therapy; pharmaceuticals and therapeutics for targeted radiation therapy; pharmaceuticals and therapeutics; medical and scientific research in the areas of pharmaceutical products and radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields of immune modulation, infection, injury, inflammation, oncology/cancer, radiology, infectious, genetic, and autoimmune diseases, and radiation, therapies; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy |
Description | Date | Event Coding |
---|---|---|
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-06-26 | 1 NWOS I:Incoming Correspondence |
ASSIGNED TO EXAMINER | 2024-02-19 | 2 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2024-02-19 | 3 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2024-02-19 | 4 GNRT F:First Action |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-02-19 | 5 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-03-08 | 6 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-03-08 | 7 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-03-08 | 8 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-03-26 | 9 CNSA P: |
WITHDRAWN FROM PUB - OG REVIEW QUERY | 2024-04-09 | 10 PBCR Z:Deletion |
PREVIOUS ALLOWANCE COUNT WITHDRAWN | 2024-04-12 | 11 ZZZX Z:Deletion |
FINAL REFUSAL WRITTEN | 2024-04-12 | 12 CNFR R:Renewal |
FINAL REFUSAL E-MAILED | 2024-04-12 | 13 GNFR O:Outgoing Correspondence |
NOTIFICATION OF FINAL REFUSAL EMAILED | 2024-04-12 | 14 GNFN O:Outgoing Correspondence |
TEAS REQUEST FOR RECONSIDERATION RECEIVED | 2024-06-28 | 15 ERFR I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-06-28 | 16 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-06-28 | 17 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2024-07-04 | 18 CNSA P: |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-07-24 | 19 NONP E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.